HAL (France)open access
Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism
Antivitamin K, Edoxaban, Low molecular weight heparin, Tranexamic acid, 0, Iron, Fondaparinux, Anticoagulant agent
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 983827
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.